Cerevel Therapeutics Inc.

CERE | NASDAQ

Price Alert Chart Builder DCF Calculator

$44.96

+$0.33 (+0.74%)

At close: Jul 31, 2024, 04:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

0.74%

(1Y)

Key Statistics

Market Data

Market Cap $8.19B

1D Range

44.96 44.99

52W Range

19.59 44.99

Valuation (TTM)

PE -16.47

PB 14.51

EV/EBITDA -16.53

Valuation (NTM)

Forward PE N/A

Forward PEG 0.48

Price Target $33.50

Cash Flow

FCF Yield -4.5%

SBC Adj. FCF Yield -5.5%

SBC Impact -21.0%

Margins

Gross Margin 0.0%

Operating Margin -5946.8%

FCF Margin -4496.6%

Growth (CAGR)

Revenue 3Y | 5Y 150.0% | 100.0%

Dil EPS 3Y | 5Y -22.6% | -21.5%

FCF 3Y | 5Y -25.2% | -31.3%

Returns

ROA -34.8%

ROE -72.4%

ROIC -38.7%

Financial Health

Net Cash

$477.99M

Current Ratio 10.92

Interest Coverage -42.33

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

A detailed description of the company is not yet available.

Sector n/a

Industry n/a

Employees n/a

IPO Date n/a

Website n/a

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.